Chen, Miao-Fen Lin, Paul-Yang Wu, Ching-Fang Chen, Wen-Cheng Wu, Chun-Te Levels of IL-6 in bladder cancer. <p>A. Levels of IL-6 were examined in six specimens (paired cancer (C) and adjacent non-malignant tissue (N); two specimens in a lane) by RT-PCR and Western blotting analysis. For real-time RT-PCR analysis, the y-axis shows the ratio of IL-6 in cancer tissue divided by that in the non-malignant specimen. Columns, mean of three separate experiments; Bars, standard deviation (SD); *, <i>P<</i>0.05. B. Immunohistochemical staining of human bladder cancer specimens with anti-IL-6 antibody. Representative slides are shown. C. The IHC data showed that IL-6 levels were significantly correlated with clinical stage. D. Urinary IL-6 levels of patients were examined by ELISA analysis. Columns, mean of three separate experiments; Bars, SD; *, <i>P<</i>0.05. (NT, patients with non-malignant diseases).</p> Anatomy and physiology;Immune physiology;cytokines;immunology;Immunologic techniques;Immunohistochemical analysis;Model organisms;Animal models;mouse;oncology;Cancer treatment;Radiation therapy;Cancers and neoplasms;Genitourinary tract tumors;Bladder cancer;Basic cancer research;Cancer risk factors;il-6;bladder 2013-04-30
    https://plos.figshare.com/articles/figure/_Levels_of_IL_6_in_bladder_cancer_/694771
10.1371/journal.pone.0061901.g001